Department of Laboratory Medicine, A Perrino Hospital, Brindisi, Italy.
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e239-46. doi: 10.1016/j.ijrobp.2011.03.058. Epub 2011 Jun 2.
Adjuvant radiotherapy (RT) after breast-conserving surgery has been associated with increased cardiovascular mortality. Cardiac biomarkers may aid in identifying patients with radiation-mediated cardiac dysfunction. We evaluated the correlation between N-terminal pro-B–type natriuretic peptide (NT-proBNP) and troponin (TnI) and the dose of radiation to the heart in patients with left-sided breast cancer.
NT-proBNP and TnI plasma concentrations were measured in 30 left-sided breast cancer patients (median age, 55.0 years) 5 to 22 months after RT (Group I) and in 30 left-sided breast cancer patients (median age, 57.0 years) before RT as control group (Group II). Dosimetric and geometric parameters of heart and left ventricle were determined in all patients of Group I. Seventeen patients underwent complete two-dimensional echocardiography.
NT-proBNP levels were significantly higher (p = 0.03) in Group I (median, 90.0 pg/ml; range, 16.7–333.1 pg/ml) than in Group II (median, 63.2 pg/ml; range, 11.0–172.5 pg/ml). TnI levels remained below the cutoff threshold of 0.07 ng/ml in both groups. In patients with NT-proBNP values above the upper limit of 125 pg/ml, there were significant correlations between plasma levels and V(3 Gy)(%) (p = 0.001), the ratios (p = 0.01), the ratios D(15 cm)(3)/D(50%) (Gy) (p = 0.008) for the heart and correlations between plasma levels and V(2 Gy) (%) (p = 0.002), the ratios (p = 0.03), and the ratios (p = 0.05) for the ventricle.
Patients with left-sided breast cancer show higher values of NT-pro BNP after RT when compared with non–RT-treated matched patients, increasing in correlation with high doses in small volumes of heart and ventricle. The findings of this study show that the most important parameters are not the mean doses but instead the small percentage of organ volumes (heart or ventricle) receiving high dose levels, supporting the notion that the heart behaves as a serial organ.
保乳手术后的辅助放疗(RT)与心血管死亡率的增加有关。心脏生物标志物可能有助于识别因辐射导致心脏功能障碍的患者。我们评估了左乳腺癌患者心脏接受放射剂量与 N 末端脑钠肽前体(NT-proBNP)和肌钙蛋白(TnI)之间的相关性。
30 例左乳腺癌患者(中位年龄 55.0 岁)在 RT 后 5 至 22 个月(I 组)和 30 例左乳腺癌患者(中位年龄 57.0 岁)在 RT 前作为对照组(II 组)中测量 NT-proBNP 和 TnI 血浆浓度。所有 I 组患者均测定心脏和左心室的剂量学和几何参数。17 例患者行完全二维超声心动图检查。
I 组 NT-proBNP 水平明显高于 II 组(中位数 90.0 pg/ml;范围 16.7-333.1 pg/ml)(p = 0.03)。两组 TnI 水平均低于 0.07 ng/ml 的截断值。在 NT-proBNP 值高于 125 pg/ml 的患者中,血浆水平与 V(3 Gy)(%)(p = 0.001)、比值(p = 0.01)、比值 D(15 cm)(3)/D(50%)(Gy)(p = 0.008)之间存在显著相关性,并且与血浆水平与 V(2 Gy)(%)(p = 0.002)、比值(p = 0.03)和比值(p = 0.05)之间存在相关性。
与未接受 RT 的匹配患者相比,接受左乳腺癌 RT 的患者 NT-proBNP 值更高,与心脏和心室小体积内的高剂量呈正相关。本研究结果表明,最重要的参数不是平均剂量,而是接受高剂量水平的器官体积(心脏或心室)的小百分比,这支持了心脏作为串联器官的观点。